-
1.发明申请公开(公告)号：US20210403592A1
公开(公告)日：2021-12-30
申请号：US17329057
申请日：2021-05-24
Applicant: Janssen Biotech, Inc.
Inventor： Tahamtan Ahmadi , Tineke Casneuf , Henk Lokhorst , Tuna Mutis , Amy Sasser , Niels van de Donk
IPC: C07K16/28 , C07K16/40 , A61K39/395 , A61K38/47 , A61K45/06 , A61K31/454 , A61K31/573
Abstract: The present invention relates to methods of immunomodulation and treating patients having solid tumors with antibodies that specifically bind CD38.
-
2.发明申请公开(公告)号：US20250066501A1
公开(公告)日：2025-02-27
申请号：US18825958
申请日：2024-09-05
Applicant: Janssen Biotech, Inc.
Inventor： Tahamtan Ahmadi , Tineke Casneuf , Henk Lokhorst , Tuna Mutis , Amy Sasser , Niels van de Donk
IPC: C07K16/28 , A61K31/454 , A61K31/573 , A61K38/47 , A61K39/00 , A61K39/395 , A61K45/06 , C07K16/40
Abstract: The present invention relates to methods of immunomodulation and treating patients having solid tumors with antibodies that specifically bind CD38.
-
公开(公告)号：US20170107295A1
公开(公告)日：2017-04-20
申请号：US15386391
申请日：2016-12-21
Applicant: Janssen Biotech, Inc.
Inventor： Henk M. Lokhorst , Tuna Mutis , Inger S Nijhof , Niels Van de Donk
IPC: C07K16/28 , A61K39/395 , A61K31/203
CPC classification number: C07K16/2896 , A61K31/203 , A61K39/39558 , A61K2039/505 , A61P35/00 , C07K2317/34 , C07K2317/51 , C07K2317/56 , C07K2317/565 , C07K2317/732 , C07K2317/734 , C07K2317/92 , A61K2300/00
Abstract: The present invention relates to combination therapies with anti-CD38 antibodies and all-trans retinoic acid.
-
公开(公告)号：US20160067205A1
公开(公告)日：2016-03-10
申请号：US14847428
申请日：2015-09-08
Applicant: Janssen Biotech, Inc.
Inventor： Henk M. Lokhorst , Tuna Mutis , Inger S Nijhof , Niels Van de Donk
IPC: A61K31/203 , A61K39/395 , C07K16/40
CPC classification number: C07K16/2896 , A61K31/203 , A61K39/39558 , A61K2039/505 , A61P35/00 , C07K2317/34 , C07K2317/51 , C07K2317/56 , C07K2317/565 , C07K2317/732 , C07K2317/734 , C07K2317/92 , A61K2300/00
Abstract: The present invention relates to combination therapies with anti-CD38 antibodies and all-trans retinoic acid.
Abstract translation: 本发明涉及与抗CD38抗体和全反式视黄酸的组合疗法。
-
5.发明授权公开(公告)号：US11021543B2
公开(公告)日：2021-06-01
申请号：US16162355
申请日：2018-10-16
Applicant: Janssen Biotech, Inc.
Inventor： Tahamtan Ahmadi , Tineke Casneuf , Henk Lokhorst , Tuna Mutis , Amy Sasser , Niels van de Donk
IPC: C07K16/28 , A61K39/395 , C07K16/40 , A61K38/47 , A61K45/06 , A61K31/454 , A61K31/573 , A61K39/00
Abstract: The present invention relates to methods of immunomodulation and treating patients having solid tumors with antibodies that specifically bind CD38.
-
Patent Agency Ranking
6.发明申请Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38 审中-公开用具体绑定CD38的抗体对实体肿瘤的免疫调节和治疗公开(公告)号：US20170044265A1
公开(公告)日：2017-02-16
申请号：US15340214
申请日：2016-11-01
Applicant: Janssen Biotech, Inc.
Inventor： Tahamtan Ahmadi , Tineke Casneuf , Henk Lokhorst , Tuna Mutis , Amy Sasser , Niels van de Donk
IPC: C07K16/28 , A61K38/47 , A61K39/395 , C07K16/40 , C07K16/30
CPC classification number: C07K16/2896 , A61K31/454 , A61K31/573 , A61K38/47 , A61K39/39558 , A61K45/06 , A61K2039/505 , A61K2039/545 , A61K2039/55 , C07K16/40 , C07K2317/56 , C07K2317/565 , C12Y204/99 , C12Y302/01035 , A61K2300/00
Abstract: The present invention relates to methods of immunomodulation and treating patients having solid tumors with antibodies that specifically bind CD38.
Abstract translation: 本发明涉及用具有特异性结合CD38的抗体免疫调节和治疗具有实体瘤患者的方法。
-
7.发明申请Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38 审中-公开用具体绑定CD38的抗体对实体肿瘤的免疫调节和治疗公开(公告)号：US20160376373A1
公开(公告)日：2016-12-29
申请号：US15191808
申请日：2016-06-24
Applicant: Janssen Biotech, Inc.
Inventor： Tahamtan Ahmadi , Tineke Casneuf , Henk Lokhorst , Tuna Mutis , Amy Sasser
IPC: C07K16/28 , A61K45/06 , C07K16/40 , A61K39/395
CPC classification number: C07K16/2896 , A61K39/39558 , A61K45/06 , A61K2039/505 , A61K2039/507 , A61K2039/545 , A61P35/00 , A61P37/04 , C07K16/2803 , C07K16/2818 , C07K16/2827 , C07K16/40 , C07K2317/31 , C07K2317/34 , C07K2317/56 , C07K2317/565 , C07K2317/70 , C07K2317/732 , C07K2317/76
Abstract: The present invention relates to methods of immunomodulation and treating patients having solid tumors with antibodies that specifically bind CD38.
Abstract translation: 本发明涉及用具有特异性结合CD38的抗体免疫调节和治疗具有实体瘤患者的方法。
-
8.发明申请Combination therapies for heme malignancies with Anti-CD38 antibodies and survivin inhibitors 审中-公开用抗CD38抗体和存活蛋白抑制剂组合治疗血红素恶性肿瘤公开(公告)号：US20160367663A1
公开(公告)日：2016-12-22
申请号：US15189577
申请日：2016-06-22
Applicant: Janssen Biotech, Inc.
Inventor： Parul Doshi , Henk M. Lokhorst , Tuna Mutis
IPC: A61K39/395 , A61K9/00 , A61K38/47 , A61K31/497
Abstract: The present invention relates to combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors.
Abstract translation: 本发明涉及用抗CD38抗体和存活蛋白抑制剂的血红素恶性肿瘤的组合疗法。
-
9.发明授权公开(公告)号：US10668149B2
公开(公告)日：2020-06-02
申请号：US15189577
申请日：2016-06-22
Applicant: Janssen Biotech, Inc.
Inventor： Parul Doshi , Henk M. Lokhorst , Tuna Mutis
IPC: A61K39/395 , A61K9/00 , C07K16/28 , A61K31/497 , A61K38/47 , A61K39/00
Abstract: The present invention relates to combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors.
-
公开(公告)号：US10604580B2
公开(公告)日：2020-03-31
申请号：US15386391
申请日：2016-12-21
Applicant: Janssen Biotech, Inc.
Inventor： Henk M. Lokhorst , Tuna Mutis , Inger S Nijhof , Niels Van de Donk
IPC: A61K39/395 , C07K16/28 , A61K31/203 , A61P35/00 , A61K39/00
Abstract: The present invention relates to combination therapies with anti-CD38 antibodies and all-trans retinoic acid.
-
-
-
-
-
-
-
-
-
Search Results
11
records
(took 0.017 seconds)
